№3 / 2022

Передовая
Pokrovsky V.V.
It was in Elista (on the occasion of the 100th anniversary of sanitary and epidemiological service) 		6-11
Epidemic situation
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V.
Prevalence of human immune deficiency virus infection in the territories of the Russian Federation in 2021 		12-18
Avksentiev N.A., Makarov A.S., Makarova Yu.V., Pazukhina E.M., Sisigina N.N., Feoktistova O.A. Zaitseva E.E., Kuznetsov S.D., Pace A., Saitkulov K.I.
The social and economic burdens of HIV in the Russian Federation 		19-25
Senkina E.L. Demchenko M.A.
The epidemic situation of HIV infection in the Ryazan Region over 2011–2020 and the impact of the COVID-19 pandemic on HIV incidence rates 		26-30
Lapovok I.A., Kirichenko A.A., Shlykova A.V., Saleeva D.V., Lopatukhin A.E., Kireev D.E., Ladnaia N.N., Musabaev E.I., Kazakova E.I., Ibadullaeva N.S., Ibragimova S.S., Safarova A.M., Kadirova A., Nurlyaminova Z., Ismatova L., Zukhurova M., Kholnazarov R., Bekbolotov A.A., Narmatova E.B., Iskanova B.M., Grigoryan T.R., Petrosyan A.R., Sargatyan T.A., Gasich E.L., Bunas A.S., Glinskaya I.N., Pokrovsky V.V.
Molecular epidemiological analysis of HIV-1 genetic variants circulating in the countries of Eastern European and Central Asia in 2010-2019 		31-40
Original investigations
Pokrovskaya A.V., Barsky K.A., Korenev D.A., Petrov A.S., Kalinin A.A., Pchelin I.V., Popova A.A.
Behavioral risks for HIV infection in men who have sex with men (according to the survey results) 		41-45
Popova A.A., Domonova E.A., Goloveshkina E.N., Gromova A.V., Makhova T.I., Petrov A.S., Korenev D.A., Barsky K.A., Pokrovskaya A.V.
Screening for STI pathogens in vulnerable groups outside of healthcaare facilities: anal canal self-swabbing 		46-53
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Kuimova I.V.
Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers 		54-58
Kanestri V.G., Kuimova U.A., Goliusova M.D.
Comparative analysis of clinical and laboratory outcomes in HIV-infected patients vaccinated and not vaccinated against COVID-19 		59-64
Belyaeva V.V., Sokolova E.V., Kozyrina N.V., Kuimova V.A., Kulabukhova E.I., Goliusova M.D.
Memory status and self-assessment of asthenia in HIV-infected patients receiving antiretroviral therapy 		65-70
Kulabukhova E.I., Kravchenko A.V., Zimina V.N., Pokrovskaya A.V., Suvorova Z.K., Khokhlova O.N., Vinokurova O.O., Kadyrova A.A., Rzaeva A.M., Sarkisyants N.K., Davidyan A.S., Sergeenko S.V., Saprykina Zh.A., Bekbolotov A.A., Abdrakhmanova E.D., Volchenkov G.V., Zamkovaya T.N.., Sattorov S.S., Soliev A.A., Bekmetova M.Yu., Normuratova G.A., Pokrovsky V.V.
Risk factors for tuberculosis in patients with HIV infection 		71-77
Reviews and lectures
Ermak T.N.
History of Peruvian wart and its relatives 		78-83
Exchange of experience
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Goliusova M.D., Kulabukhova E.I., Kanestri V.G., Kozyrina N.V., Mityurina E.V.
The efficiency and safety of ART after switching patients to the combined Russian NRTI phosphaladine in combination with elsulfavirine 		84-90
Leneva I.A., Gracheva A.V., Korchevaya E.R., Smirnova D.I., Faizuloev E.V.
Experimental study of the effect of the active substance of miramistin® on the infectious activity of SARS-CoV-2 in vitro 		91-96

Бионика Медиа